Evidence for selection of doxycycline resistance in Staphylococcus aureus in DoxyPrEP study

Diagnostic Uncertainties and Delayed Treatment Protocols Impact Efficacy of FMT for C. Difficile Infection

• Extract

Clostridioides difficile: Treating Sustained Antibiotic Responders With Fecal Microbiota Transplantation Does Not Improve Efficacy

• Extract

Fecal Microbiota Transplantation in Clostridioides Difficile Infections: Rethinking the Approach by Patient Profile in Light of New Evidence

• Extract

More Than Meets the Eye: Interpreting Results of a Negative Trial

• Extract

FMT for Recurrent Clostridioides difficile Infection

• Extract

Vancomycin-Resistant Enterococci-Active Perioperative Prophylaxis for Liver Transplant Patients Requires Attention to the Gut Microbiota

• Extract

Specifying targeted antibiotic treatment options for spinal implant infections

Plasma Quantitative Microbial Cell-Free DNA for Staphylococcal Cardiac Implantable Electronic Device Infection – Too Soon?

Subgroup analyses in randomized trials of Clostridioides difficile associated disease: Recurring Challenges with Analyzing Recurrence

Shifting the Focus in Acute SARS-CoV-2 Management to Include Prevention of Long COVID Get access

• Extract

No Evidence for Time-Dependent Treatment Effect of Oseltamivir for Adults Hospitalized With Influenza A Get access

• Extract

Case Definitions in Encephalitis Get access

• Extract

Low Diagnostic Accuracy of Encephalitis Criteria Hinders Interpretation of the Absence of Cerebrospinal Fluid Pleiocytosis Get access

• Extract

Chronic Pulmonary Aspergillosis Is a Differential Diagnosis and Co-infection With Nontuberculous Mycobacterial Pulmonary Disease Get access

• Extract

Chronic Pulmonary Aspergillosis and Nontuberculous Mycobacterial Pulmonary Disease: Two Peas in a Pod Get access

• Extract

Giving Aztreonam-Ceftazidime-Avibactam Its Best Chance Get access

• Extract

Reply to Aztreonam-Ceftazidime-Avibactam May Not Be Enough Get access

• Extract

Bridging Ophthalmology and Infectious Diseases: Insights into the Pathophysiology of Retinal Necrosis Get access

• Extract

Enhancing Influenza Vaccination for Adults Aged 50–64Years: Addressing Moderate Vaccine Efficacy Get access

• Extract